0.93 USD
↗ 0.07 (7.66%)LIVE (AS OF 02:13 PM EDT)
Lantern Pharma Inc. Common Stock
LTRNNASDAQ • USD
Market: OPEN
Lantern Pharma Inc. Common Stock (LTRN) is currently trading at $0.93. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (579.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Oct 2, 2026.
Open?$0.88
High?$0.93
Low?$0.86
Prev. Close?$0.86
Volume?173.8K
Avg. Volume?246.2K
VWAP?$0.90
Rel. Volume?0.71x
Bid / Ask
Bid?$0.80 × 100
Ask?$1.06 × 100
Spread?$0.26
Midpoint?$0.93
Valuation & Ratios
Market Cap?12.8M
Shares Out?12.8M
Float?8.6M
Float %?67.3%
P/E Ratio?N/A
P/B Ratio?-3.99
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Themes
Employees
16
Market Cap
12.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-11
Address
1920 MCKINNEY AVENUE
DALLAS, TX 75201
Phone: 972-277-1136
DALLAS, TX 75201
Phone: 972-277-1136
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?49
Piotroski F-Score?0/9Weak
Altman Z-Score?-21.56Distress
Confidence?44%Low
Short InterestElevated
Short % of Float?6.50%Elevated
Short Interest?558.0K
Days to Cover?3.3
Free Float8.6M
Avg Daily Volume167.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.96Adequate
Quick Ratio?1.96Adequate
Cash Ratio?1.54Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-3.99CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?579.8%STRONG▾
Peers50
S&P97
ROA?-216.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-14078189
Enterprise Value?$6.2M
Fundamentals ratios updated end of day